Blood News and Research

RSS

Missing gene plays role in autism

It is estimated that three to six out of every 1,000 children in the United States have autism - and the number of diagnosed cases is rising.

8 Feb 2009

FDA approves orphan drug ATryn anticoagulant

The U.S. Food and Drug Administration has issued its first approval for a biological product produced by genetically engineered (GE) animals.

8 Feb 2009

FDA approves first ablation catheters for the treatment of atrial fibrillatio

The U.S. Food and Drug Administration has approved the first ablation catheters for the treatment of atrial fibrillation (uncoordinated contractions of the upper heart chambers), one of the most common types of arrhythmias-or abnormal heart rhythms--affecting more than two million Americans.

8 Feb 2009

Emergency physicians question antibiotic guidelines for pneumonia

A new study from Wake Forest University Baptist Medical Center that assessed emergency physicians understanding of time-based, antibiotic treatment guidelines for community-acquired pneumonia (CAP) found that more than half believed they prescribed antibiotics needlessly in order to comply with guidelines.

8 Feb 2009

Research to explore why lupus therapies work for some, not others

The results should shed light not only on the mechanisms behind the disease, but more broadly on the workings of our immune system, especially how our bodies churn out and "train" key combat-ready immune cells, called B-cells.

8 Feb 2009

Even moderate exercise helps breast cancer recovery

Australian researchers have found that exercise can offer benefits to women recovering from breast cancer treatment.

8 Feb 2009

Salt and the City is a killer and we're awash with it!

A new Australian survey on fast foods has revealed that some manufacturers are delivering an astonishing amount of salt in some of their products.

8 Feb 2009

Consumers warned about over-the-counter pharmacy diets

Pharmacies across Australia are offering a range of over-the-counter diet plans designed to encourage people to invest in weight loss programs.

8 Feb 2009

Good news for folks is bad news for mozzies!

Australian scientists have good news for folks but bad news for 'mozzies' with the discovery a possible new treatment for malaria.

8 Feb 2009

Extra copies of LIS1 gene carry extra risk

Is more of a good thing better? A gene known as LIS1 is crucial for ensuring the proper placement of neurons in the developing brain.

5 Feb 2009

Researchers discover "master gene" behind blood vessel development

In a first of its kind discovery, University of Minnesota researchers have identified the "master gene" behind blood vessel development.

5 Feb 2009

Study tests salsalate anti-inflammatory for poorly controlled type 2 diabetes

Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D).

5 Feb 2009

Source of cancer stem cells' resistance to radiation discovered

Much to the dismay of patients and physicians, cancer stem cells - tiny powerhouses that generate and maintain tumor growth in many types of cancers - are relatively resistant to the ionizing radiation often used as therapy for these conditions.

5 Feb 2009

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences, Inc. has announced that its collaborators at the University of Pennsylvania have opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS.

5 Feb 2009

Research to provide information of long-term effects of childhood cancer treatment to parents

Researchers from the neuropsychology department and pediatric hematology/oncology department at Rhode Island Hospital and its Hasbro Children's Hospital have published the results of their findings on parents' needs for information about the neurocognitive late effects (NCLE) of treatment for childhood cancer.

5 Feb 2009

FDA issues early communication about Xigris safety

The U.S. Food and Drug Administration has announced that it is working with the maker of Xigris (drotrecogin alfa activated), Eli Lilly and Company, to further evaluate the incidence of serious bleeding events and death in patients who receive Xigris, a drug used to treat severe sepsis (a blood stream infection).

5 Feb 2009